Innoviva, Inc. — Director's Dealing 2012

Dec 7, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: THERAVANCE INC (THRX)
CIK: 0001080014
Period of Report: 2012-12-04

Reporting Person: Shafer Bradford J (Sr VP, Gen. Counsel, Secretary)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-12-04	3% Convvertible Subordinated Notes due 2015	$25.87	S		Disposed	2015-01-15	Common Stock (5798)	Direct

Footnotes

F1: Convertible notes are exercisable at any time prior to the close of business on the business day immediately preceding the Expiration Date.

F2: Price received includes $1,775 of accrued interest.